Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 16 Jul 2018 – 20 Aug 2026, limited by ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund | Nifty 500 |
|---|---|---|
| 16 Jul 2018 | ₹100.00 | ₹100.00 |
| 19 Mar 2019 | ₹101.52 | ₹103.67 |
| 21 Nov 2019 | ₹102.63 | ₹105.21 |
| 24 Jul 2020 | ₹139.09 | ₹98.43 |
| 28 Mar 2021 | ₹156.06 | ₹131.61 |
| 29 Nov 2021 | ₹168.89 | ₹158.77 |
| 03 Aug 2022 | ₹158.99 | ₹161.17 |
| 06 Apr 2023 | ₹144.95 | ₹159.88 |
| 08 Dec 2023 | ₹181.72 | ₹202.61 |
| 11 Aug 2024 | ₹234.34 | ₹248.32 |
| 14 Apr 2025 | ₹227.07 | ₹224.81 |
| 17 Dec 2025 | ₹233.64 | ₹254.53 |
| 20 Aug 2026 | ₹235.25 | ₹254.71 |
| Metric | ICICI Prudential · Regular · IDCW NAV ₹23.29 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| -0.47% | +3.54% | |
| +12.31% | +11.47% | |
| +6.26% | +9.70% | |
| — | +10.32% | |
| +11.15% | +9.15% | |
| +8.55% | — | |
| +13.22% | +12.10% | |
| +12.84% | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 15.67% | 15.91% | |
| 0.37 | 0.25 | |
| 0.47 | 0.32 | |
| -29.44% | -26.14% | |
| Nifty 500 | — | |
| +2.10% | -0.04% | |
| 0.85 | 0.98 | |
| 92.1% | 98.3% | |
| 81.7% | 101.5% | |
| 2.08% | 2.38% | |
| ₹60.01Cr | ₹1,160Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 78% | 42% | |
| Sharmila D'silva | — | |
| 16 Jul 2018 | — | |
| 35 | — | |
| 59.3% | — | |
| 4.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.